{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:55Z","timestamp":1786119355731,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/wnf.0b013e3181a7fd00","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T10:39:24Z","timestamp":1253875164000},"page":"297-298","source":"Crossref","is-referenced-by-count":10,"title":["Olanzapine-Induced Clinical Seizure"],"prefix":"10.1097","volume":"32","author":[{"given":"Rishikesh V.","family":"Behere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divakaran","family":"Anjith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren P.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Venkatasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangalore N.","family":"Gangadhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.ajp.159.1.109","article-title":"EEG abnormalities during treatment with typical and atypical antipsychotics.","volume":"159","author":"Centorrino","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1192\/bjp.178.1.85-a","article-title":"Lowered seizure threshold on olanzapine.","volume":"178","author":"Woolley","year":"2001","journal-title":"BrJ Psychiatry"},{"issue":"3","key":"R3-12-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2000-7976","article-title":"A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia.","volume":"33","author":"Schuld","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00023210-200418090-00005","article-title":"Dose response and atypical antipsychotics in schizophrenia.","volume":"18","author":"Kinon","year":"2004","journal-title":"CNS Drugs"},{"issue":"4","key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food andDrug Administration (FDA) summary basis of approval reports.","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"5","key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1345\/aph.17385","article-title":"Seizure associated with olanzapine.","volume":"33","author":"Lee","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"7-8","key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1345\/aph.18399","article-title":"Fatal status epilepticus associated with olanzapine therapy.","volume":"33","author":"Wyderski","year":"1999","journal-title":"Ann Pharmacother"},{"issue":"1","key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1345\/aph.1C288","article-title":"Olanzapine-associated seizure.","volume":"37","author":"Bonelli","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"3","key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.wnf.0000165351.10841.fa","article-title":"Olanzapine-induced myoclonic status.","volume":"28","author":"Camacho","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hup.537","article-title":"EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine,haloperidol and healthy subjects.","volume":"18","author":"Amann","year":"2003","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"R11-12-20210203","first-page":"491","article-title":"Seizures associated with sertraline.","volume":"45","author":"Raju","year":"2000","journal-title":"Can J Psychiatry"},{"issue":"2","key":"R12-12-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimatingthe probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181a7fd00","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:37Z","timestamp":1786039117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200909000-00012"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181a7fd00","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}